Most PAH patients who completed one year in a CS1 expanded access program had stable or improved clinical measures.
(RTTNews) - BrainStorm Cell Therapeutics Inc. (BCLI) said the FDA recommended that the company submit an EAP protocol amendment to provide additional dosing of NurOwn for participants who completed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results